Harbor Capital Advisors, Inc. Kiniksa Pharmaceuticals, Ltd. Transaction History
Harbor Capital Advisors, Inc.
- $2.3 Billion
- Q3 2024
A detailed history of Harbor Capital Advisors, Inc. transactions in Kiniksa Pharmaceuticals, Ltd. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 97,543 shares of KNSA stock, worth $2.06 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
97,543Holding current value
$2.06 Million% of portfolio
0.11%Shares
2 transactions
Others Institutions Holding KNSA
# of Institutions
8Shares Held
1.95MCall Options Held
0Put Options Held
0-
Pictet Asset Management Sa Geneva 73, V81.52MShares$32 Million0.03% of portfolio
-
Spearhead Capital Advisors, LLC Wellington, FL203KShares$4.27 Million2.82% of portfolio
-
Putnam Investments LLC Boston, MA39.5KShares$832,7590.0% of portfolio
-
Birchview Capital, LP Burlington, VT30KShares$632,7000.69% of portfolio
-
Credit Suisse Ag Zurich, V828.9KShares$610,0070.0% of portfolio
About Kiniksa Pharmaceuticals, Ltd.
- Ticker KNSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,470,400
- Market Cap $727M
- Description
- Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...